147 related articles for article (PubMed ID: 32006189)
1. Synergism of 4HPR and SAHA increases anti-tumor actions in glioblastoma cells.
Khathayer F; Taylor MA; Ray SK
Apoptosis; 2020 Apr; 25(3-4):217-232. PubMed ID: 32006189
[TBL] [Abstract][Full Text] [Related]
2. Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis.
Chiu SP; Batsaikhan B; Huang HM; Wang JY
Sensors (Basel); 2019 May; 19(10):. PubMed ID: 31100944
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro.
Abou Najem S; Khawaja G; Hodroj MH; Rizk S
Curr Mol Pharmacol; 2019; 12(4):281-300. PubMed ID: 30868973
[TBL] [Abstract][Full Text] [Related]
4. N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.
Janardhanan R; Butler JT; Banik NL; Ray SK
Brain Res; 2009 May; 1268():142-153. PubMed ID: 19285047
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.
Chen J; Luo B; Wen S; Pi R
Invest New Drugs; 2020 Jun; 38(3):755-764. PubMed ID: 31414267
[TBL] [Abstract][Full Text] [Related]
6. Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines.
Khathayer F; Ray SK
Neurochem Res; 2020 Oct; 45(10):2336-2351. PubMed ID: 32683533
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
[TBL] [Abstract][Full Text] [Related]
8. A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers.
Zhu S; Chen Z; Wang L; Peng D; Belkhiri A; Lockhart AC; El-Rifai W
Clin Cancer Res; 2018 Apr; 24(8):1905-1916. PubMed ID: 29386219
[No Abstract] [Full Text] [Related]
9. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells.
Chiao MT; Cheng WY; Yang YC; Shen CC; Ko JL
Autophagy; 2013 Oct; 9(10):1509-26. PubMed ID: 23962875
[TBL] [Abstract][Full Text] [Related]
10. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
Chakrabarti M; Ray SK
Brain Res; 2015 Dec; 1629():85-93. PubMed ID: 26471408
[TBL] [Abstract][Full Text] [Related]
12. Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.
Sun SY; Schroeder CP; Yue P; Lotan D; Hong WK; Lotan R
Cancer Biol Ther; 2005 Apr; 4(4):407-13. PubMed ID: 15846100
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-(4-hydroxyphenyl)retinamide-induced apoptosis in breast cancer cells by galectin-3.
Choi JH; Chun KH; Raz A; Lotan R
Cancer Biol Ther; 2004 May; 3(5):447-52. PubMed ID: 15326375
[TBL] [Abstract][Full Text] [Related]
15. N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death.
Tosetti F; Venè R; Arena G; Morini M; Minghelli S; Noonan DM; Albini A
Mol Pharmacol; 2003 Mar; 63(3):565-73. PubMed ID: 12606763
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells.
Lim SJ; Simeone AM; Kim CK; Tari AM
Int J Cancer; 2002 Sep; 101(3):243-7. PubMed ID: 12209974
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
Zhou X; Yang XY; Popescu NC
Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
[TBL] [Abstract][Full Text] [Related]
18. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
Appierto V; Tiberio P; Villani MG; Cavadini E; Formelli F
Carcinogenesis; 2009 May; 30(5):824-31. PubMed ID: 19325135
[TBL] [Abstract][Full Text] [Related]
19. Suberoylanilide hydroxamic acid attenuates epidural fibrosis via inhibiting myofibroblast differentiation and increasing fibroblast apoptosis.
Yang JS; Liu P; Liu JJ; Chu L; Li J; Chen C; Yan L; Liu TJ; Chen H; Hao DJ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5726-5733. PubMed ID: 32495908
[TBL] [Abstract][Full Text] [Related]
20. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
Oridate N; Suzuki S; Higuchi M; Mitchell MF; Hong WK; Lotan R
J Natl Cancer Inst; 1997 Aug; 89(16):1191-8. PubMed ID: 9274913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
